Happy Clinic

Regeneration
Precise Medicine
Rehabilitation
Prevention Care

Hong-Ming Technology Co., Ltd.

Hong-Ming Technology (HMT) has specialized optical design ability and particularly specializes in manufacturing, integrating, and developing optical measurement systems and related application.
The customers include HTC, BYD, CWT, TPK, LENS Technology, CATCHER Technology , YFO, AUO, Chimei, Giga Solar Materials Corp. and etc.
With plenty of hands-on experience and expertise, HMT could provide technical consultative service and high quality measurement equipment.
Meanwhile, developing instruments for testing touch panel IR hole/sensor and the icon, HMT received great reputation from clients.
HMT regards “profession, innovation, and meeting customers’ requirements” as the utmost purpose to become the most trust-worthy brand to customers.
Exhibits: Optical Measurement System

Hsinchu Science Park Bureau, Ministry of Science and Technology

The exhibition booths of the HSP showcase research and development competence and achievements of 10 biotechnology firms. Biomedical industry is the fastest growing sector of HSP, which has 8.3 % compound annual growth rate in revenue at last 5 years. Hsinchu Biomedical Park is an advanced biomedical industry cluster for cultivating diversified applications, e.g. high-end medical equipment, new drug and vaccines, featured medical technologies, to promote regional high-tech industry development.

https://www.provitaebio.com

"ProScreen" gene testing to test the patient's genetic data, and provide the doctor as a reference basis for selection of target drug. "ProScreen" uses next-generation sequencing genetic screening technology to detect 523 genetic data related to immune check point drugs and target drugs for tumor tissues and blood samples at a time. The detection range is wider, more comprehensive, and further assist physicians to choose accurate and suitable medication for patients.

I CARE BIOTECH

1.Peripheral Blood Stem Cell storage service
2.Joint care

iCare Diagnostics International Co., Ltd.

iCareDx PSS-1s RT-PCR assay platform leverages electrowetting on dielectric technologies for accurate liquid handling and precise thermal control.

It is designed to detect RNA of SARS-CoV-2 virus in saliva from patients suspected of COVID-19.

For each of the tests, a total of 300uL of saliva sample is collected by passive drooling with the standard protocol.

The assay utilizes lyophilized reagents and primers to detect SARS-CoV-2 virus RNA.

The result will be automatically analyzed with AI interpretation and shown instantly on the device screen.

ICON INC.

Puritan Medical products

Illumina

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

Institute of Atomic and Molecular Science, Academia Sinica

Instrument Development of QMIA - Quantitative Mobile Immunoassay reader. For help on the identification of borderline for the pandemic outbreak and public health situation, our lab developed a portable, easy-to-use, and robust instrument for both antigen and neutralizing antibody concentration in a simple way. The purpose of this instrument could be applied to understand the isolation borderline and current public health status as well as for future disease diagnosis.

Japan Tobacco Inc.

JT Pharma, the Pharmaceutical Division of Japan Tobacco Corporation (including Akros Pharma, US; Torii Pharmaceuticals, Japan) is dedicated to the discovery, development, and sales of novel human therapeutics.